Related Experiment Video
Updated: Jan 4, 2026
05:41
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
3.3K
Fecal bacteriotherapy for recurrent Clostridium difficile infection
1St. Luke's Hospital, Infectious Disease Associates, 1001 East Superior Street, Suite L201 Duluth, MN 55802, USA. jbakken1@d.umn.edu
Anaerobe
|September 26, 2009
Summary
Fecal bacteriotherapy offers a promising treatment for recurrent Clostridium difficile infection (CDI) by restoring gut bacteria. This approach shows high success rates, avoiding repeated antibiotic use and associated resistance.
Area of Science:
- Microbiology
- Gastroenterology
- Infectious Diseases
Background:
- Clostridium difficile infection (CDI) is a significant complication of systemic antimicrobial therapy.
- Antibiotic use disrupts gut flora, leading to C. difficile overgrowth, toxin production, and colitis.
- Standard treatments (metronidazole, vancomycin) have relapse rates of 5-35%.
Purpose of the Study:
- To evaluate the efficacy of fecal bacteriotherapy for chronic or relapsing CDI.
- To present an alternative treatment to conventional antibiotic therapies for CDI.
Main Methods:
- Fecal bacteriotherapy involves instilling stool from a healthy donor into the gastrointestinal tract.
- The procedure can be performed via various routes (e.g., upper or lower GI tract).
Main Results:
- Fecal bacteriotherapy demonstrated a high success rate, approaching 90% in a cohort of 100 patients.
- This method effectively treated patients with chronic or relapsing CDI unresponsive to conventional therapies.
Conclusions:
- Fecal bacteriotherapy is a low-tech, effective treatment for recurrent CDI.
- It offers an alternative to repeated antibiotic courses, reducing antibiotic resistance and healthcare costs.
Related Concept Videos
01:17Drugs for Treatment of Diarrhea-Predominant IBS
573
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
573
01:21Drugs for Treatment of Constipation-Predominant IBS
648
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
648
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
388
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
388
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
585
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
585
01:29Bacterial Flora of the Large Intestine
1.5K
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.5K
01:21Inflammatory Bowel Disease V: Surgical Management
411
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
411